NEUROPROTECTION FOR GLAUCOMA

This article discusses Memantine, a glutamate antagonist (glutamate is toxic to the optic nerve), being developed by Allergan and undergoing phase III FDA clinical trials. It is touted as a neuroprotectant.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

Keratoconus and Inflammatory Skin Conditions

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH